{
    "clinical_study": {
        "@rank": "154793", 
        "acronym": "PreFaiR", 
        "arm_group": [
            {
                "arm_group_label": "misoprostol plus mifepristone", 
                "arm_group_type": "Active Comparator", 
                "description": "800 micrograms vaginal misoprostol, preceded by 200 milligrams oral mifepristone 24 hours prior"
            }, 
            {
                "arm_group_label": "misoprostol", 
                "arm_group_type": "Active Comparator", 
                "description": "800 micrograms of vaginal misoprostol alone"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare the effectiveness of combination treatment\n      (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol\n      (standard of care) for the management of early pregnancy failure."
        }, 
        "brief_title": "Comparative Effectiveness of Pregnancy Failure Management Regimens", 
        "completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Early Pregnancy Failure", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  between 5 and 12 completed weeks gestation\n\n          -  18 years or older\n\n          -  hemodynamically stable\n\n          -  confirmed diagnosis of intrauterine embryonic/fetal demise or anembryonic gestation\n             (ultrasound examination demonstrates a fetal pole without cardiac activity measuring\n             between 5.3 and 40 mm or an anembryonic gestational sac between 21 and 45 mm, or\n             growth less than 2 mm over a 5 day period or less than 3 mm over a 7 day period)\n\n          -  willing and able to give informed consent\n\n        Exclusion Criteria:\n\n          -  diagnosis of incomplete or inevitable abortion (absent gestational sac and/or active\n               bleeding, open cervical os)\n\n          -  contraindication to mifepristone (chronic corticosteroid administration, adrenal\n             disease)\n\n          -  contraindication to misoprostol (glaucoma, mitral stenosis, sickle cell anemia, or\n             known allergy to prostaglandin)\n\n          -  cardiovascular disease (angina, valvular disease, arrhythmia, or cardiac failure)\n\n          -  hemoglobin <9.5 g/dL\n\n          -  known clotting defect or receiving anticoagulants\n\n          -  pregnancy with an IUD in place\n\n          -  breastfeeding\n\n          -  unwilling to comply with the study protocol and visit schedule\n\n          -  any evidence of viable pregnancy\n\n          -  possibility of ectopic pregnancy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02012491", 
            "org_study_id": "818434", 
            "secondary_id": "1R01HD071920-01A1"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "misoprostol plus mifepristone", 
                    "misoprostol"
                ], 
                "intervention_name": "Misoprostol", 
                "intervention_type": "Drug", 
                "other_name": "Cytotec"
            }, 
            {
                "arm_group_label": "misoprostol plus mifepristone", 
                "intervention_name": "Mifepristone", 
                "intervention_type": "Drug", 
                "other_name": "Mifeprex"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Mifepristone", 
                "Misoprostol"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 10, 2013", 
        "location": [
            {
                "contact": {
                    "email": "mitchell.creinin@ucdmc.ucdavis.edu", 
                    "last_name": "Mitchell Creinin, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "University of California, Davis Medican Center"
                }, 
                "investigator": {
                    "last_name": "Mitchell Creinin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "schreibe@upenn.edu", 
                    "last_name": "Courtney Schreiber, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "University of Pennsylvania"
                }, 
                "investigator": {
                    "last_name": "Courtney Schreiber, MD, MPH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparative Effectiveness of Pregnancy Failure Management Regimens", 
        "overall_official": [
            {
                "affiliation": "University of Pennsylvania", 
                "last_name": "Courtney A Schreiber, MD, MPH", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of California, Davis", 
                "last_name": "Mitchell Creinin, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Gestational sac expulsion with one treatment dose and no need for additional medical or surgical intervention.", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02012491"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pennsylvania", 
            "investigator_full_name": "Courtney Schreiber", 
            "investigator_title": "Assistant Professor of Obstetrics and Gynecology", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "University of Pennsylvania", 
        "sponsors": {
            "collaborator": {
                "agency": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Courtney Schreiber", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}